🇯🇵·Jan 1, 1970CDMO
Apr 22,2026 | FJ3, API Manufacturing Building for Small Molecule and Macrocyclic Peptide Drugs at the Fujieda Plant, Receives the 2026 Facility of the Year Awards from ISPE in the Honorable Mention Category | News | CHUGAI PHARMACEUTICAL CO., LTD.
Publisher
C
Chugai Pharmaceutical
Japan
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Chugai Pharmaceutical
- Region
- Japan
- Scope
- CDMO
- Published
- January 1, 1970
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on chugai-pharm.co.jp
Leave the platform to read the original full article on the publisher site.
Source: Chugai Pharmaceutical
Scope: CDMO
Related coverage
More related coverage
LatestLY/8h ago
Maharashtra FDA Suspends Licences of These 5 Clubs in Mumbai Over Food Safety Violations; Check Names Here
Politico/8h ago
FDA panel to consider previously spurned drugs
PR Newswire/8h ago
Ono Pharmaceutical partners with Phylo to embed agentic AI with every discovery scientist
Recordati/8h ago